Home > Boards > US Listed > Medical - Equipment > Guardion Health Sciences Inc. (GHSI)

They have until March 18th, 2020 to meet

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
hmuney Member Profile
Member Level 
Followed By 2
Posts 144
Boards Moderated 0
Alias Born 03/19/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2019 4:24:02 PM
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019 GlobeNewswire Inc. - 11/14/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 5:27:30 PM
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering GlobeNewswire Inc. - 10/30/2019 12:33:22 PM
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering GlobeNewswire Inc. - 10/28/2019 9:21:39 AM
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF GlobeNewswire Inc. - 10/23/2019 7:00:05 AM
Guardion® Announces Statistically Significant Blood Assay Study Results GlobeNewswire Inc. - 10/10/2019 10:30:00 AM
Guardion Health Sciences Acquires the NutriGuard Brand of Products GlobeNewswire Inc. - 9/23/2019 10:30:00 AM
Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test GlobeNewswire Inc. - 9/3/2019 7:00:00 AM
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering GlobeNewswire Inc. - 8/15/2019 4:05:00 PM
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering GlobeNewswire Inc. - 8/15/2019 8:35:14 AM
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering GlobeNewswire Inc. - 8/13/2019 9:00:00 AM
Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations GlobeNewswire Inc. - 8/12/2019 8:40:00 AM
Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-C... GlobeNewswire Inc. - 8/6/2019 7:00:00 AM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the Hong Kong Patents Registry GlobeNewswire Inc. - 7/17/2019 7:00:00 AM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union GlobeNewswire Inc. - 6/20/2019 7:00:00 AM
Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’ GlobeNewswire Inc. - 6/4/2019 7:00:00 AM
Guardion’s Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Functi... GlobeNewswire Inc. - 5/9/2019 10:14:43 AM
Guardion's Lumega-Z Formula Associated with Improved Vision in Patients with Severe Glaucoma GlobeNewswire Inc. - 5/7/2019 7:00:00 AM
Guardion Health Sciences, Inc. Receives Official Trademark Registrations in China GlobeNewswire Inc. - 5/1/2019 7:00:00 AM
Results of Lumega-Z Data to be Presented at ARVO GlobeNewswire Inc. - 4/17/2019 9:01:23 AM
WallachBeth Capital Announces Completion of the $5 Million IPO for Guardion Health Services PR Newswire (US) - 4/11/2019 9:18:00 AM
Guardion Health Sciences, Inc. Announces Closing of Initial Public Offering GlobeNewswire Inc. - 4/9/2019 12:20:13 PM
Guardion Health Sciences, Inc. Announces Pricing of Initial Public Offering Business Wire - 4/5/2019 12:49:00 PM
hmuney Member Level  Wednesday, 10/02/19 11:31:26 AM
Re: yaboy520 post# 311
Post # of 411 
They have until March 18th, 2020 to meet the $1.00 Minimum Bid Price Requirement and can be eligible to extend that date by 180 more days.

"In accordance with Nasdaq listing rules, the Company has been provided an initial period of 180 calendar days, or until March 18, 2020 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. If, at any time during this 180-day period, the closing bid price of the Company’s common stock is at least $1.00 for a minimum of 10 consecutive business days, the Staff will provide the Company written confirmation of compliance with the Minimum Bid Price Requirement and the matter will be closed. If the Company does not regain compliance by the Compliance Date, the Company may be eligible for an additional 180 calendar day compliance period."

https://fintel.io/doc/sec-ghsi-8k-guardion-health-sciences-2019-september-26-18165

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist